178 related articles for article (PubMed ID: 38718717)
21. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri.
Martín-Escolano R; Yiangou L; Kazana E; Robinson GK; Michaelis M; Tsaousis AD
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():204-212. PubMed ID: 34875573
[TBL] [Abstract][Full Text] [Related]
22. Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment.
Chao-Pellicer J; Arberas-Jiménez I; Fuchs F; Sifaoui I; Piñero JE; Lorenzo-Morales J; Scheid P
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627700
[TBL] [Abstract][Full Text] [Related]
23. Assessing the risk of primary amoebic meningoencephalitis from swimming in the presence of environmental Naegleria fowleri.
Cabanes PA; Wallet F; Pringuez E; Pernin P
Appl Environ Microbiol; 2001 Jul; 67(7):2927-31. PubMed ID: 11425704
[TBL] [Abstract][Full Text] [Related]
24. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
[TBL] [Abstract][Full Text] [Related]
25. Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.
Jamerson M; Schmoyer JA; Park J; Marciano-Cabral F; Cabral GA
Microbiology (Reading); 2017 Mar; 163(3):322-332. PubMed ID: 28086072
[TBL] [Abstract][Full Text] [Related]
26. Differential Growth Rates and
Russell AC; Kyle DE
Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
[TBL] [Abstract][Full Text] [Related]
27. Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri.
Arberas-Jiménez I; Rizo-Liendo A; Nocchi N; Sifaoui I; Chao-Pellicer J; Souto ML; Suárez-Gómez B; Díaz-Marrero AR; Fernández JJ; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2022 Mar; 147():112694. PubMed ID: 35131659
[TBL] [Abstract][Full Text] [Related]
28. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Shah MR; Siddiqui R
ACS Chem Neurosci; 2019 Jun; 10(6):2692-2696. PubMed ID: 30970208
[TBL] [Abstract][Full Text] [Related]
29. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
[TBL] [Abstract][Full Text] [Related]
30. Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
Siddiqui R; Mungroo MR; Anuar TS; Alharbi AM; Alfahemi H; Elmoselhi AB; Khan NA
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740156
[TBL] [Abstract][Full Text] [Related]
31. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
32. Genotyping and Molecular Identification of Acanthamoeba Genotype T4 and Naegleria fowleri from Cerebrospinal Fluid Samples of Patients in Turkey: Is it the Pathogens of Unknown Causes of Death?
Aykur M; Dirim Erdogan D; Selvi Gunel N; Guler A; Biray Avci C; Celebisoy N; Gunduz C; Dagci H
Acta Parasitol; 2022 Sep; 67(3):1372-1383. PubMed ID: 35864411
[TBL] [Abstract][Full Text] [Related]
33. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-Terpene Fusion: A Game-Changer in Combating Primary Amoebic Meningoencephalitis Caused by
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Omega; 2024 Mar; 9(10):11597-11607. PubMed ID: 38497026
[TBL] [Abstract][Full Text] [Related]
35. In silico discovery of diagnostic/vaccine candidate antigenic epitopes and a multi-epitope peptide vaccine (NaeVac) design for the brain-eating amoeba Naegleria fowleri causing human meningitis.
Köseoğlu AE; Özgül F; Işıksal EN; Şeflekçi Y; Tülümen D; Özgültekin B; Deniz Köseoğlu G; Özyiğit S; Ihlamur M; Ekenoğlu Merdan Y
Gene; 2024 Apr; 902():148192. PubMed ID: 38253295
[TBL] [Abstract][Full Text] [Related]
36. Zinc Oxide Nanoconjugates against Brain-Eating Amoebae.
Siddiqui R; Boghossian A; Akbar N; Jabri T; Aslam Z; Shah MR; Alharbi AM; Alfahemi H; Khan NA
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289939
[No Abstract] [Full Text] [Related]
37. Gold-Conjugated Curcumin as a Novel Therapeutic Agent against Brain-Eating Amoebae.
Mungroo MR; Anwar A; Khan NA; Siddiqui R
ACS Omega; 2020 Jun; 5(21):12467-12475. PubMed ID: 32548431
[No Abstract] [Full Text] [Related]
38.
Debnath A; Nelson AT; Silva-Olivares A; Shibayama M; Siegel D; McKerrow JH
Front Microbiol; 2018; 9():414. PubMed ID: 29559968
[TBL] [Abstract][Full Text] [Related]
39. A Fluorometric Assay for the
Arberas-Jiménez I; Rizo-Liendo A; Sifaoui I; Chao-Pellicer J; Piñero JE; Lorenzo-Morales J
Microbiol Spectr; 2022 Aug; 10(4):e0051522. PubMed ID: 35862997
[TBL] [Abstract][Full Text] [Related]
40. Swimming with death: Naegleria fowleri infections in recreational waters.
Heggie TW
Travel Med Infect Dis; 2010 Jul; 8(4):201-6. PubMed ID: 20970721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
